The complement inhibitor, CRIT, undergoes clathrin-dependent endocytosis

Experimental Cell Research

Volumn 310, Issue 1, 2005, Pages 54-65

  Inal, Jameel ^a,b   Miot, Sylvie ^a   Schifferli, Jürg A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BETA ARRESTIN; CHLORPROMAZINE; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C2 RECEPTOR INHIBITOR TRISPINNING; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3A RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT INHIBITOR; COMPLEMENT RECEPTOR; FILIPIN; NYSTATIN; UNCLASSIFIED DRUG;

ARTICLE; CAVEOLA; CELL MEMBRANE; CONTROLLED STUDY; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INCUBATION TIME; LEUKEMIA CELL LINE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 25844471011     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.07.003     Document Type: Article

References (63)

1. J.M. Inal, K.-M. Hui, S. Miot, S. Lange, M.I. Ramirez, B. Schneider, G. Krueger, and J.A. Schifferli Complement C2 receptor inhibitor trispanning (CRIT) a novel human complement inhibitory receptor J. Immunol. 174 2005 356 366
2. J.M. Inal Schistosoma TOR (trispanning orphan receptor), a novel, antigenic surface receptor of the blood-dwelling, Schistosoma parasite Biochim. Biophys. Acta 1445 1999 283 298
3. K.S. Oh, M.H. Kweon, K.H. Rhee, K.H. Lee, and H.C. Sung Inhibition of complement activation by recombinant Sh-CRIT-ed1 analogues Immunology 110 2003 73 79
4. J.M. Inal, and J.A. Schifferli Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2 J. Immunol. 168 2002 5213 5221
5. K.S. Oh, D.K. Na, M.H. Kweon, and H.C. Sung Expression and purification of the anticomplementary peptide Sh-CRIT-ed1 (formerly Sh-TOR-ed1) as a tetramultimer in Escherichia coli Protein Expr. Purif. 27 2003 202 209
6. J.M. Inal, and R.B. Sim A Schistosoma protein, Sh-TOR, is a novel inhibitor of complement which binds human C2 FEBS Lett. 470 2000 131 134
7. P.S. McPherson, B.K. Kay, and N.K. Hussain Signalling on the endocytic pathway Traffic 2 2001 375 384
8. A. Spiegel β-arrestin-Not just for G protein-coupled receptors Science 301 2003 1338 1339
9. S. Mayor, S. Sabharanjak, and F.R. Maxfield Cholesterol-dependent retention of GPI-anchored proteins in endosomes EMBO J. 17 1998 4626 4638
10. B. Settmacher, C. Rheinheimer, H. Hamacher, R.S. Ames, A. Wise, L. Jenkinson, D. Bock, M. Schaefer, J. Köhl, and A. Klos Structure-function of the C3a-receptor: C-terminal serine and threonine residues which influence receptor internalization and signalling Eur. J. Immunol. 33 2003 920 927
11. L. Braun, T. Christophe, and F. Boulay Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via β-arrestin, dynamin and clathrin-dependent pathway J. Biol. Chem. 278 2003 4277 4285
12. R. Reca, D. Mastellos, M. Majka, L. Marquez, J. Ratajczak, S. Franchini, A. Glodek, M. Honczarenko, L.A. Spruce, A. Janowska-Wieczorek, J.D. Lambris, and M.Z. Ratajczak Functional receptor for C3a anaphylatoxin is expressed by normal hemopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1 Blood 101 2003 3784 3793
13. T.J. Oglesby, C.J. Allen, M.K. Liszewski, D.J. White, and J.P. Atkinson Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism J. Exp. Med. 175 1992 1547 1551
14. B. Crimeen-Irwin, S. Ellis, D. Christiansen, M.J. Ludford-Menting, J. Milland, M. Lanteri, B.E. Loveland, D. Gerlier, and S.M. Russell Ligand binding determines whether CD46 is internalized by clathrin-coated pits or macropinocytosis J. Biol. Chem. 278 2003 46927 46937
15. G. Wang, M.K. Liszewski, and J.P. Atkinson Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation J. Immunol. 164 2000 1839 1846
16. S.J. Singer The structure and insertion of integral proteins in membranes Annu. Rev. Cell Biol. 6 2000 247 296
17. M.S. Robinson, C. Watts, and M. Zerial Membrane dynamics in endocytosis Cell 84 1996 13 21
18. J.E. Heuser, and R.G. Anderson Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation J. Cell Biol. 108 1989 389 400
19. A. Sorkin, and G. Carpenter Interaction of activated EGF receptors with coated pit adaptins Science 261 1993 612 615
20. K.G. Rothberg, Y.-S. Ying, B.A. Kamen, and R.G. Anderson Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate J. Cell Biol. 111 1990 2931 2938
21. J.E. Schnitzer, P. Oh, E. Pinney, and J. Allard Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules J. Cell Biol. 127 1994 1217 1232
22. E. Fire, O. Gutman, M.G. Roth, and Y.I. Henis Dynamic or stable interactions of influenza hemagglutinin mutants with coated pits J. Biol. Chem. 270 1995 21075 21081
23. A. Wells, and U. Marti Signalling shortcuts: cell-surface receptors in the nucleus? Nat. Rev., Mol. Cell Biol. 3 2002 697 702
24. S.-Y. Lin, K. Makino, W. Xia, A. Matin, Y. Wen, K.Y. Kwong, L. Bourguignon, and M.-C. Hung Nuclear localization of EGF receptor and its potential new role as a transcription factor Nat. Cell Biol. 3 2001 802 808
25. L.A. Volpicelli, J.J. Lah, and A.I. Levey Rab5-dependent trafficking of the m4 muscarinic acetylcholine receptor to the plasma membrane, early endosomes, and multivesicular bodies J. Biol. Chem. 276 2001 47590 47598
26. L.-H. Wang, K.G. Rothberg, and R.G. Anderson Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation J. Cell Biol. 123 1993 1107 1117
27. A. Sofer, and A.H. Futerman Cationic amphiphilic drugs inhibit the internalization of cholera toxin to the Golgi apparatus and the subsequent elevation of cyclic AMP J. Biol. Chem. 270 1995 12117 12122
28. A.M. Fra, M.E. Williamson, K. Simons, and R.G. Parton Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae J. Biol. Chem. 269 1994 30745 30748
29. I.R. Nabi, and P.U. Le Caveolae/raft-dependent endocytosis J. Cell Biol. 161 2003 673 677
30. E.J. Smart, Y.-S. Ying, P.A. Conrad, and R.G. Anderson Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation J. Cell Biol. 127 1994 1185 1197
31. K.G. Rothberg, J.E. Heuser, W.C. Donzell, Y. Ying, J.R. Glenney, and R.G. Anderson Caveolin, a protein component of caveolae membrane coats Cell 68 1992 673 682
32. W.G. Thomas, K.M. Baker, T.J. Motel, and T.J. Thekkumkara Angiotensisn II receptor endocytosis involves two distinct regions of the cytoplasmic tail J. Biol. Chem. 270 1995 22153 22159
33. A. Subtil, A. Rocca, and A. Dautry-Varsat Molecular characterization of the signal responsible for the targeting of the interleukin 2 receptor β-chain toward intracellular degradation J. Biol. Chem. 273 1998 29424 29429
34. A. Subtil, M. Delepierre, and A. Dautry-Varsat An α-helical signal in the cytosolic domain of the interleukin 2 receptor β-chain mediates sorting towards degradation after endocytosis J. Cell Biol. 136 1997 583 595
35. J.S. Bonifacino, and L.M. Traub Signals for sorting of transmembrane proteins to endosomes and lysosomes Annu. Rev. Biochem. 72 2003 395 447
36. W.S. Chen, C.S. Lazar, K.A. Lund, J.B. Welsh, C.-P. Chang, G.M. Walton, C.J. Der, H.S. Wiley, G.N. Gill, and M.G. Rosenfeld Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalisation and calcium regulation Cell 59 1989 33 43
37. N. Blom, S. Gammeltoft, and S. Brunak Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites J. Mol. Biol. 294 1999 1351 1362
38. C. Harter, and I. Mellman Transport of the lysosomal membrane glycoprotein lgp120 (lgp-A) to lysosomes does not require appearance on the plasma membrane J. Cell Biol. 117 1992 311 325
39. K.M. Liszewski, T.W. Post, and J.P. Atkinson Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster Annu. Rev. Immunol. 9 1991 431 455
40. T. Kirchhausen, J.S. Bonifacino, and H. Riezman Linking cargo to vesicle formation: receptor tail interactions with coat proteins Curr. Opin. Cell Biol. 9 1997 488 495
41. N. Isakov ITAMs: immunoregulatory scaffolds that link immunoreceptors to their intracellular signalling pathways Recept. Channels 5 1998 243 253
42. B.J. Mayer, and R. Gupta Functions of SH2 and SH3 domains Curr. Top. Microbiol. Immunol. 228 1998 1 22
43. M. Hochstrasser Ubiquitin-dependent protein degradation Annu. Rev. Genet. 30 1996 405 439
44. L. Hicke Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels Trends Cell Biol. 9 1999 107 112
45. S. Polo, S. Sigismund, M. Faretta, M. Guidi, M.R. Capua, G. Bossi, H. Chen, P. De Camilli, and P.P. Di Fiore A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins Nature 416 2002 451 455
46. G.J. Strous, P. Vankerkhof, R. Govers, A. Ciechanover, and A.L. Schwartz The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor EMBO J. 15 1996 3806 3812
47. J.S. Bonifacino, and A.M. Weissman Ubiquitin and the control of protein fate in the secretory and endocytic pathways Annu. Rev. Cell Dev. Biol. 14 1998 19 57
48. W.R. Hein, L. Dudler, W.L. Marston, T. Landsverk, A.J. Young, and D. Avila Ubiquitination and dimerization of complement receptor type 2 on sheep B cells J. Immunol. 161 1998 458 466
49. S.S. Ferguson, J. Zhang, L.S. Barak, and M.G. Caron Role of β-arrestins in the intracellular trafficking of G-protein-coupled receptors Adv. Pharmacol. 42 1998 420 424
50. S.S. Ferguson, W.E. Downey III, A.M. Colapietro, L.S. Barak, L. Menard, and M.G. Caron Role of β-arrestin in mediating agonist-promoted G protein-coupled receptor internalisation Science 271 1996 363 366
51. C. Murdoch, and A. Finn Chemokine receptors and their role in inflammation and infectious diseases Blood 95 2000 3032 3043
52. W. Chen, K.C. Kirkbride, and T. How β-Arrestin-2 mediates endocytosis of type III TGF-β receptor and down-regulation of its signalling Science 301 2003 1394 1397
53. I.S. Trowbridge, J.F. Collawn, and C.R. Hopkins Signal-dependent membrane protein trafficking in the endocytic pathway Annu. Rev. Cell Biol. 9 1993 129 161
54. Z. Songyang, S.E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W.G. Haser, F. King, T. Roberts, S. Ratnofsky, R.J. Lechleider, B.G. Neel, R.B. Birge, J.E. Fajardo, M.M. Chou, H. Hanafusa, B. Schaffhausen, and L.C. Cantley SH2 domains recognise specific phosphopeptide sequences Cell 72 1993 767 778
55. D.R. Bentley Primary structure of human complement component C2. Homology to two unrelated protein families Biochem. J. 239 1986 339 345
56. F. Praz, and E. Ruuth Growth-supporting activity of fragment Ba of the human alternative complement pathway for activated murine B lymphocytes J. Exp. Med. 163 1986 1349 1354
57. M.G. Peters, J.L. Ambrus Jr., A.S. Fauci, and E.J. Brown The Bb fragment of complement factor B acts as a B cell growth factor J. Exp. Med. 168 1988 1225 1235
58. J.L. Ambrus, M.G. Peters, A.S. Fauci, and E.J. Brown The Ba fragment of complement factor B inhibits human B lymphocyte proliferation J. Immunol. 144 1990 1549 1553
59. J.L. Ambrus Jr., L. Chesky, and T. Chused Intracellular signalling events associated with the induction of proliferation of normal human B lymphocytes by two different antigenically related human B cell growth factors (high molecular weight B cell growth factor (HMW-BCGR) and the complement factor Bb) J. Biol. Chem. 266 1991 3702 3708
60. J. Cheng, and J.E. Volanakis Alternatively spliced transcripts of the human complement C2 gene J. Immunol. 152 1992 1774 1782
61. H. Tsukamoto, A. Tousson, A. Circolo, R.B. Marchase, and J.E. Volanakis Calnexin is associated with and induced by overexpressed human complement protein C2 Anat. Rec. 267 2002 7 16
62. K.-M. Hui, G.L. Orriss, T. Schirmer, B. Magnadottir, J.A. Schifferli, and J.M. Inal Expression of functional recombinant von Willebrand factor-A domain from human complement C2: potential binding site for C4 and CRIT Biochem. J. 389 2005 863 868
63. J.M. Inal Parasite interaction with host complement: beyond attack regulation Trends Parasitol. 20 2004 407 412